Humacyte, Inc. (HUMA) Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. Nkarta, Inc. (NKTX) Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. […]
Read MoreAvidity Biosciences, Inc. (RNA) Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. Jumia Technologies AG (JMIA) Jumia Technologies AG operates an e-commerce platform in West Africa, North Africa, East and South Africa, Europe, the United […]
Read MoreCorbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare, chronic, and serious inflammatory and fibrotic diseases. Their leading product candidates include anti-inflammatory and anti-fibrotic therapies that target the endocannabinoid system, aiming to provide significant therapeutic benefits for patients with limited treatment […]
Read MoreHumacyte, Inc. is a biotechnology company focused on developing and commercializing bioengineered human tissues and organs. Their primary product, the Human Acellular Vessel (HAV), is designed to address the unmet needs in vascular surgery and hemodialysis access. These bioengineered vessels aim to improve patient outcomes by offering a reliable and durable alternative to synthetic and […]
Read MoreLENZ Therapeutics, Inc. (LENZ) LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Applied Therapeutics, Inc. (APLT) Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in […]
Read MoreJanux Therapeutics Inc. JANX is a biotechnology company specializing in the development of novel cancer immunotherapies designed to enhance the body’s ability to harness the immune system to combat cancer. The company focuses on creating therapies that are not only effective but also have reduced side effects, improving patient outcomes in the fight against cancer. […]
Read MoreVera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is […]
Read MoreJasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2024-03-27. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 21.62 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2024-03-26. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 21.46 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2024-03-25. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 21.33 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreMarket conditions are Bullish in a Bull Market as of 2024-03-22. This means traders and investors should consider trading with a Bullish bias by buying (going long) stocks, long ETF’s or Call Options. The rank of the Bull Market is 21.19 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreSera Prognostics, Inc. (SERA) Sera Prognostics, Inc., a women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. Spotify Technology S.A. (SPOT) Spotify Technology S.A., together with its subsidiaries, provides audio streaming subscription services worldwide. It operates through two segments, Premium and Ad-Supported. Kodiak Sciences Inc. (KOD) […]
Read MoreMind Medicine (MindMed) Inc. (MNMD) is a biotechnology company focused on the discovery, development, and deployment of psychedelic-inspired medicines and therapies to address mental health and neurological conditions. The company is primarily involved in clinical research and trials to explore the therapeutic potential of psychedelics like LSD, MDMA, psilocybin, and ibogaine in treating conditions such […]
Read MoreJanux Therapeutics Inc (JANX) is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The company aims to harness the power of the immune system to target and eliminate cancer cells. Their approach involves creating novel therapeutics that can stimulate the body’s immune response against tumors, potentially leading to improved outcomes for patients with various […]
Read More